Anti-MYL9 antibody [EPR13012(2)]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal MYL9 antibody. Suitable for IP, WB, IHC-P and reacts with Human, Rat, Mouse samples. Cited in 10 publications.
View Alternative Names
MLC2, MRLC1, MYRL2, MYL9, Myosin regulatory light polypeptide 9, 20 kDa myosin light chain, MLC-2C, Myosin RLC, Myosin regulatory light chain 9, Myosin regulatory light chain MRLC1, LC20
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling MYL9 with ab191393 at 1/700 dilution followed by pre-diluted HRP Polymer for Rabbit IgG secondary antibody and counter-stained with Hematoxylin. Inset : Negative control : using PBS instead of primary antibody.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
Immunohistochemical analysis of paraffin-embedded Rat colon tissue labeling MYL9 with ab191393 at 1/700 dilution followed by pre-diluted HRP Polymer for Rabbit IgG secondary antibody and counter-stained with Hematoxylin. Inset : Negative control : using PBS instead of primary antibody.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
Lanes 1-4 : Merged signal (red and green). Green - ab191393 observed at 20 kDa. Red - loading control ab8245 observed at 37 kDa.
ab191393 Anti-MYL9 antibody [EPR13012(2)] was shown to specifically react with MYL9 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab266036 (knockout cell lysate ab256999) was used. Wild-type and MYL9 knockout samples were subjected to SDS-PAGE. ab191393 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-MYL9 antibody [EPR13012(2)] (ab191393) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human MYL9 knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-myl9-knockout-hela-cell-lysate-ab256999'>ab256999</a>) at 20 µg
Lane 3:
Human colon cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Lanes 1 - 4:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution
Predicted band size: 20 kDa
Observed band size: 20 kDa,37 kDa
false
- WB
Supplier Data
Western blot - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
All lanes:
Western blot - Anti-MYL9 antibody [EPR13012(2)] (ab191393) at 1/1000 dilution
Lane 1:
Human stomach lysate at 20 µg
Lane 2:
Human colon cancer lysate at 20 µg
Lane 3:
Human uterus lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 20 kDa
false
- WB
Supplier Data
Western blot - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
All lanes:
Western blot - Anti-MYL9 antibody [EPR13012(2)] (ab191393) at 1/1000 dilution
Lane 1:
C6 cell lysate at 10 µg
Lane 2:
PC12 cell lysate at 10 µg
Lane 3:
NIH 3T3 cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 20 kDa
false
- WB
Supplier Data
Western blot - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
The identity of the higher MW bands are unknown.
In Western blot, Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade (ab176842) staining at 1/100000 dilution.
In Western blot, Anti-MYL9 antibody [EPR13012 (2)] (ab191393) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (<a href='/en-us/products/primary-antibodies/myl9-ps20-myl12a-ps19-myl12b-ps20-antibody-epr27203-65-ab316750'>ab316750</a>) at 1/1000 dilution
Lane 1:
Untreated HeLa (human epithelial cell line from cervical adenocarcinoma) whole cell lysate (untreated membrane) at 45 µg with 5% NFDM/TBST
Lane 2:
HeLa treated with 100ng/ml Calyculin A for 15 minutes, whole cell lysate (untreated membrane) at 45 µg with 5% NFDM/TBST
Lane 3:
Untreated HeLa (human epithelial cell line from cervical adenocarcinoma) whole cell lysate (alkaline phosphatase treated membrane) at 45 µg with 5% NFDM/TBST
Lane 4:
HeLa treated with 100ng/ml Calyculin A for 15 minutes, whole cell lysate (alkaline phosphatase treated membrane) at 45 µg with 5% NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 20 kDa,15 kDa
false
Exposure time: 70s
- IP
Supplier Data
Immunoprecipitation - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
Western blot analysis of immunoprecipitation pellet from Human stomach lysate immunoprecipitated using ab191393 at 1/40 dilution (lane 1) or PBS control (lane 2).
Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-MYL9 antibody [EPR13012(2)] (ab191393)
Predicted band size: 20 kDa
false
- WB
Supplier Data
Western blot - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
All lanes:
Western blot - Anti-MYL9 antibody [EPR13012(2)] (ab191393) at 1/5000 dilution
All lanes:
rat stomach lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 20 kDa
false
- WB
Supplier Data
Western blot - Anti-MYL9 antibody [EPR13012(2)] (AB191393)
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
In Western blot, Anti-MYL9 antibody [EPR13012 (2)] (ab191393) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (<a href='/en-us/products/primary-antibodies/myl9-ps20-myl12a-ps19-myl12b-ps20-antibody-epr27203-65-ab316750'>ab316750</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with human MYL9 expression vector containing a myc-His-tag® then treated with 100/ml calyculin for 15 minutes, whole cell lysate at 20 µg with 5% NFDM/TBST
Lane 2:
293T (human embryonic kidney epithelial cell) cells transfected with human MYL9 (S20A mutant) expression vector containing a myc-His-tag® then treated with 100/ml calyculin for 15 minutes, whole cell lysate at 20 µg with 5% NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 25 kDa,36 kDa
false
Exposure time: 180s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5457 PubMed40593547
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the Association for Research in Otolaryngology : JARO 26:225-238 PubMed40240732
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biochemistry and biophysics 82:127-137 PubMed37801199
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genes 14: PubMed37239403
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:425 PubMed36273228
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular research 118:1564-1582 PubMed33757117
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 45: PubMed33760214
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 11:593966 PubMed33424621
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 20:5050-5058 PubMed31638214
2019
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 12:e0175280 PubMed28388691
2017
Applications
IHC-P
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com